Allspring Global Investments’s Adaptive Biotechnologies ADPT Stock Holding History

Allspring Global Investments’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-11,459	Closed	-$62.5K	–	2220
2023 Q3	$62.5K	Sell	11,459 -9,892	-46%	-$65.4K	﹤0.01%	2186
2023 Q2	$143K	Buy	21,351 +160	+0.8%	+$1.19K	﹤0.01%	1927
2023 Q1	$187K	Buy	21,191 +3,128	+17%	+$27.6K	﹤0.01%	1837
2022 Q4	$138K	Buy	18,063 +9,462	+110%	+$73.6K	﹤0.01%	1953
2022 Q3	$61K	Buy	+8,601	New	+$81K	﹤0.01%	2269

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

AAP

Aristotle Atlantic Partners Sarasota, Florida $2.14B AUM 37.01% 1-Year Est. Return

Allspring Global Investments's ADPT Position: Q4 2023 in Review

Allspring Global Investments sold out of Adaptive Biotechnologies (ADPT) in Q4 2023, closing a stake of 11,459 shares — an estimated $62.5K sold.

Allspring Global Investments first reported a position in ADPT in Q3 2022 and held it in 5 quarters. The position peaked at $187K in Q1 2023. 200 funds tracked by Wall St. Rank hold ADPT as of Q4 2023.

Allspring Global Investments reported no remaining Adaptive Biotechnologies position as of Q4 2023 after selling out during the quarter.
Allspring Global Investments sold 11,459 Adaptive Biotechnologies shares in Q4 2023, an estimated $62.5K.
Allspring Global Investments first reported a position in Adaptive Biotechnologies in Q3 2022 and held it in 5 quarters.
Allspring Global Investments's Adaptive Biotechnologies position peaked at $187K in Q1 2023.
200 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.